DNA Valley with Kelly Schulz
Vložit
- čas přidán 6. 09. 2024
- Jeff Galvin, CEO of AGT, talks with Kelly Schulz, CEO of the Maryland Tech Council about the advantages of entrepreneurship in Maryland. Looking to the future, both CEOs talk about the incubators for new businesses, the pool of talented workers in the area, non-traditional routes to success such as apprenticeships, and the how the rising tide of the gene therapy industry can turn the area into a gathering point for creative minds from all over the country.
The Maryland Tech Council's influence on the development of high-tech and biotech industries in our local area has been pronounced and consistent. In reference to the digital revolution centered in Silicon Valley, Maryland's DNA Valley is a thriving ecosystem of innovative companies, regulatory agencies, and collaborative opportunities with a united goal: improve society through the development of biological technologies. Pharmaceuticals, agricultural products, diagnostics, and gene therapies are being developed within DNA valley. Between the Maryland Tech Council's support, the proximity to federal regulators, access to roads and rails, and the concentration of highly educated individuals, DNA valley is the perfect place to turn ideas into businesses.
More about the Maryland Tech Council mdtechcouncil....
About American Gene Technologies®
AGT™ is a gene and cell therapy company with a proprietary gene-delivery platform for rapid development of cell and gene therapies to cure infectious diseases, cancers, and inherited disorders. AGT™'s mission is to transform people's lives through genetic medicines that rid the body of disease. AGT™ has been granted four patents for the technology used to make AGT103-T and 11 patents for its unique immuno-oncology approach to stimulate gamma-delta (γδ) T cells to destroy a variety of solid tumors. The company has developed a synthetic gene for treating Phenylketonuria (PKU), a debilitating inherited disease. AGT™'s treatment for PKU has been granted Orphan Drug Designation by the Food and Drug Administration (FDA), and it is expected to reach the clinic in 2022.
Visit our website: www.americange...
Subscribe to our newsletter: bit.ly/3ughPNR
Follow AGT on social media!
Twitter:
Jeff - @jeffreygalvin - / jeffreygalvin
AGT™ - @americangene - / americangene
LinkedIn:
Jeff - / jeff-galvin
AGT™ - / amer. .
Facebook: / amerigene
Instagram: / americangen. .
Dear sir agt is our hope please give us therapy for hiv cure we are watching you with hope 🤗
I really hope to see in the news that finally the world has defeated HIV. It would be great news to know that. Please guys the world has faith in this ❤❤
Would be great if AGT could get Emergency Use Authorization from the FDA for HIV cure. There's a chance people getting meds from govt. programs could lose their coverage due to the immigration situation.
Why agt is not disclosing agt103 -t phase 1 clinical trial after completed phase 1 we are waiting agt please find cure of hiv
Analyzing the data from from the trials takes a lot of time and we need to make sure that all of our processes are correct in order to move on to phase 2 and release data from phase 1.
@@AmericanGeneTechnologies thank you sir we have only one hope that is agt 103 - t god bless you 🙏
Well done
We r waiting for agt hiv cure but this wait is going to be endless some time wait for cure frustrates us and brings us deep mental pain .
We understand your frustration and can promise that we are working as fast and as hard as we can to bring a cure to the world.
@@AmericanGeneTechnologies i'm from vietnam.
Thanks you so much 😍
Hiv kesin tedavi istiyoruz lütfen😢😢👍👍
Most likely 2025
@@cfh4201969 I assure you that I want the definitive treatment more than anything in this world, but to say that it will be ready in 2025 is unrealistic 🤷♂️
Hope the cure is going well